通过降低CLDN1表达的调节,PABPC3驱动卵巢癌转移和药物敏感性
Hong Zhang1,2, Yiping Lin1, Mintao Ji3
1The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou Medical College of Soochow University, Suzhou, China.
Cell death & disease
|November 17, 2025
概括
聚A结合蛋白细胞质蛋白3 (PABPC3) 驱动卵巢癌转移,并降低患者的存活率. 向PABPC3可能为这种致命的恶性瘤提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 卵巢癌是一种致命的恶性瘤,由于转移而导致的死亡率高.
- 转移和治疗耐药性使管理复杂化,并降低生存率.
研究的目的:
- 为了确定卵巢癌转移的关键调节者.
- 阐明PABPC3在卵巢癌进展和患者预后中的作用.
主要方法:
- 临床样本的单核RNA测序.
- 功能性实验 (体外和体外模型).
- 在患者组织中分析PABPC3和CLDN1表达.
主要成果:
- 过度表达PABPC3会增加卵巢癌细胞的增殖,迁移和转移.
- PABPC3调节了CLDN1的表达,影响了紧结的完整性.
- 高PABPC3表达与较短的总体和无进展生存时间相关.
结论:
- PABPC3是卵巢癌转移的关键调节剂.
- PABPC3代表了一种潜在的治疗点,可以改善卵巢癌患者的治疗结果.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K


